Research & Development
Alvotech and Teva secure US launch date for Eylea biosimilar AVT06
19 December 2025 - European biotechnology company Alvotech S.A. (NASDAQ: ALVO) and Teva Pharmaceuticals, a US affiliate of Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), ...
Egetis initiates rolling US NDA for Emcitate in MCT8 deficiency
19 December 2025 - Swedish pharmaceutical company Egetis Therapeutics AB (STO:EGTX) said on Friday that it has initiated a rolling New Drug Application submission to the U.S. Food and Drug Administrat...
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
19 December 2025 - Global healthcare company Abbott (NYSE:ABT) announced on Thursday that it has received US Food and Drug Administration (FDA) approval and CE Mark for its Amplatzer Piccolo Delivery ...
Amphix Bio announces initial closing of USD12.5m seed financing round
19 December 2025 - Amphix Bio, a company spun out from Northwestern University in Chicago, Illinois, developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), announced on Thur...
BiBBInstruments reports additional US orders during targeted EndoDrill GI launch
17 December 2025 - Swedish cancer diagnostics company BiBBInstruments AB (Spotlight: BIBB) said on Wednesday that it received additional fourth-quarter orders from its US distributor TaeWoong Medical ...
Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema
17 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced late Tuesday that the European Medicines Agency has granted orphan designation to efdoralprin alfa ...